Enanta Pharmaceuticals Ownership | Who Owns Enanta Pharmaceuticals?
Enanta Pharmaceuticals Ownership Summary
Enanta Pharmaceuticals is owned by 10.09% institutional investors, 6.57% insiders, and 83.34% retail investors. Farallon capital management is the largest institutional shareholder, holding 9.96% of ENTA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.95% of its assets in Enanta Pharmaceuticals shares.
ENTA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Enanta Pharmaceuticals | 10.09% | 6.57% | 83.34% |
Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Farallon capital management | 2.11M | 9.96% | $12.12M |
Blackrock funding, inc. /de | 2.04M | 9.64% | $11.73M |
Vanguard group | 1.98M | 9.38% | $11.41M |
Blackrock | 1.85M | 8.72% | $23.96M |
Morgan stanley | 1.46M | 6.88% | $18.89M |
Millennium management | 1.35M | 6.33% | $7.44M |
Krensavage asset management | 1.25M | 5.91% | $16.23M |
Marshall wace, llp | 930.09K | 4.40% | $5.35M |
Acadian asset management | 849.42K | 4.01% | $4.88M |
Northern trust | 845.12K | 3.99% | $10.96M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Krensavage asset management | 1.25M | 7.45% | $16.23M |
Stonepine capital management | 590.74K | 3.17% | $3.26M |
Sio capital management | 177.00K | 0.29% | $977.06K |
Farallon capital management | 2.11M | 0.06% | $12.12M |
Sherbrooke park advisers | 33.45K | 0.06% | $192.34K |
Tang capital management | 126.66K | 0.05% | $728.27K |
Portland global advisors | 33.19K | 0.02% | $190.81K |
Pdt partners | 33.45K | 0.02% | $192.33K |
Quest partners | 22.26K | 0.02% | $128.00K |
Acadian asset management | 849.42K | 0.01% | $4.88M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 1.35M | 0.00% | 449.94K |
Stonepine capital management | 590.74K | 3.17% | 258.84K |
Blackrock funding, inc. /de | 2.04M | 0.00% | 139.32K |
Krensavage asset management | 1.25M | 7.45% | 126.75K |
Dimensional fund advisors lp | 297.11K | 0.00% | 102.65K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ra capital management | - | - | -1.04M |
Armistice capital | - | - | -1.00M |
Soleus capital management | - | - | -785.55K |
Morgan stanley | 1.46M | 0.00% | -588.59K |
Ameriprise financial | 70.43K | 0.00% | -257.88K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Thrivent financial for lutherans | 44.10K | 0.00% | 44.10K | $254.00K |
Norges bank | 40.70K | - | 40.70K | $234.03K |
Sherbrooke park advisers | 33.45K | 0.06% | 33.45K | $192.34K |
Bank of montreal /can/ | 31.75K | 0.00% | 31.75K | $182.55K |
Gsa capital partners llp | 30.73K | 0.01% | 30.73K | $177.00K |
Sold Out
Holder | Change |
---|---|
Ifp advisors | -3.00 |
Nelson, van denburg & campbell wealth management group | -4.00 |
Innealta capital | -16.00 |
Voisard asset management group | -28.00 |
Gamma investing | -29.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 5 | -95.33% | 2,149,611 | -88.86% | 10 | 0.12% | 2 | -96.61% | 1 | -96.55% |
Dec 31, 2024 | 32 | -71.17% | 5,786,937 | -72.69% | 27 | 0.27% | 17 | -69.09% | 9 | -71.88% |
Sep 30, 2024 | 111 | 11.00% | 21,189,162 | -3.74% | 100 | 0.93% | 56 | 27.27% | 32 | -27.27% |
Jun 30, 2024 | 100 | -6.54% | 22,011,926 | -1.25% | 103 | 0.94% | 44 | 4.76% | 44 | -12.00% |
Mar 31, 2024 | 107 | 1.90% | 22,290,570 | 11.98% | 105 | 1.18% | 42 | -22.22% | 50 | 16.28% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 629.60K | 2.95% | - |
Vanguard Total Stock Mkt Idx Inv | 629.60K | 2.95% | - |
iShares Russell 2000 ETF | 515.73K | 2.41% | 252.00 |
Vanguard Strategic Small-Cap Equity Inv | 338.10K | 1.58% | 37.34K |
Vanguard Institutional Extnd Mkt Idx Tr | 294.95K | 1.38% | - |
Columbia Small Cap Value I A | 271.73K | 1.28% | 3.30K |
Vanguard VIF Small Co Gr | 206.07K | 0.97% | -47.29K |
Columbia Small Cap Value I | 200.68K | 0.95% | 200.68K |
Fidelity Small Cap Index | 200.20K | 0.94% | - |
Vanguard Strategic Equity Inv | 180.74K | 0.85% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 12, 2025 | Luly Jay R. | President and CEO | Buy | $256.05K |
Dec 06, 2024 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | $18.40K |
Dec 06, 2024 | Luu Brendan | Chief Business Officer | Sell | $18.40K |
Dec 06, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Sell | $6.98K |
Dec 06, 2024 | Or Yat Sun | Chief Scientific Officer | Sell | $20.88K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | 1 | - |
2024 Q4 | - | 6 |
2024 Q3 | - | 3 |
2024 Q2 | - | 1 |
2024 Q1 | - | - |
ENTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools